ARCHIVES

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

January 25, 2008

Funding opportunities listed.

October 17, 2003

Cancer Meetings Listed

April 18, 1997

Cancer Control Budget Still $4 Million Short

January 28, 1977

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986